Arrhythmias & electrophysiology

A mobile relational agent to enhance atrial fibrillation self-care: Primary and secondary outcomes of a randomized controlled trial

Am Heart JPublished Randomised controlled trial

Primary result · Adjusted mean PDCResult — go to the resultOdds ratio 1.26 95% CI 0.66–2.38

Authors' conclusion

The smartphone-based relational agent intervention did not achieve its primary endpoint of increased anticoagulation adherence but did yield decreased health care utilization.

Study context

Population
Individuals with atrial fibrillation (AF) taking anticoagulation
Participants
243 individuals
Comparison
Smartphone-based relational agent plus heart rhythm monitor vs smartphone health education app plus the same monitor
Primary endpoint
Anticoagulation adherence: proportion of days covered (PDC) from pharmacy claims
Follow-up
12 months
Methodological detailsattention-controlled
  • Attention-controlled

Primary result

Adjusted mean PDC

Odds ratio

1.26

95% CI 0.66–2.38

By group

Intervention

0.88

adjusted mean · 95% CI 0.84–0.93

Attention control

0.85

adjusted mean · 95% CI 0.81–0.90

Intervention vs Attention control
OR 1.26 (95% CI 0.66–2.38)

As reported in the abstract

Secondary outcomes

Self-reported nonadherence and quality of life (QOL)

Did not differ by study arm

Health care utilization

ED visits and hospitalizations significantly less with intervention than attention control
P < 0.001
Number of days hospitalized significantly less with intervention than attention control
P = 0.004

Original publication

A mobile relational agent to enhance atrial fibrillation self-care: Primary and secondary outcomes of a randomized controlled trial. Am Heart J. Published 20 June 2025. doi:10.1016/j.ahj.2025.06.009

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.